Stock Report: CareFusion Corp. (CFN) Report Updated: May 20, 2013 | Print This Page

CareFusion Corporation, a medical technology company, provides various healthcare products and services in the United States and internationally. It operates in two segments, Critical Care Technologies, and Medical Technologies and Services. The Critical Care Technologies segment develops, manufactures, and markets equipment and related supplies for infusion, medication and supply dispensing, and respiratory care. This segment’s products include intravenous medication safety and infusion therapy delivery systems comprising disposables, software applications, and related patient monitoring equipments; automated dispensing machines and related applications for distributing and managing medication and medical supplies; and equipment and supplies for ventilation, and respiratory and sleep diagnostics. The Medical Technologies and Services segment develops, manufactures, and markets single-use skin antiseptic and other patient-preparation products; reusable surgical instruments; hair-removal and skin-care products; neurological monitoring and diagnostic equipment; and interventional specialty products, such as diagnostic trays and biopsy needles, drainage catheters, and vertebral augmentation products. This segment also provides software-based infection detection services. The company primary sells its products under the Alaris, Pyxis, AVEA, Pulmonetic Systems, Jaeger, SensorMedics, ChloraPrep, and V. Mueller brands. It primarily serves hospitals and other healthcare facilities comprising oncology clinics, ambulatory surgical centers, clinics, long-term care facilities, and physician offices. CareFusion Corporation sells its products and services through a combination of direct sales representatives, wholesalers, and third-party distributors. The company was incorporated in 2009 and is headquartered in San Diego, California.